E. Schallmach

发表

Predicting and controlling the reactivity of immune cell populations against cancer

Uri Alon, U. Alon, Y. Mandel-Gutfreund, 2009, Molecular systems biology.

Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy.

J. Schachter, G. Markel, M. Besser, 2009, Cytotherapy.

Collection of Large-scale Expanded Lymphocyte Cultures for Adoptive Immunotherapy Using a COBE Spectra Apheresis Machine

J. Schachter, A. Nagler, M. Besser, 2008, Journal of immunotherapy.

Inhibition and superactivation of the calcium-stimulated isoforms of adenylyl cyclase

Z. Vogel, T. Avidor-Reiss, E. Schallmach, 2007, Journal of Molecular Neuroscience.

Minimally Cultured or Selected Autologous Tumor-infiltrating Lymphocytes After a Lympho-depleting Chemotherapy Regimen in Metastatic Melanoma Patients

E. Segal, B. Shalmon, J. Schachter, 2009, Journal of immunotherapy.

Regulation of adenylate cyclase type VIII splice variants by acute and chronic Gi/o-coupled receptor activation.

Z. Vogel, T. Avidor-Reiss, E. Schallmach, 2005, The Biochemical journal.

Adenylyl cyclase type-VIII activity is regulated by Gβγ subunits

Z. Vogel, W. Simonds, E. Schallmach, 2006 .

Adenylyl cyclase type-VIII activity is regulated by G(betagamma) subunits.

Z. Vogel, W. Simonds, E. Schallmach, 2006, Cellular signalling.

D2/D3 Dopamine Receptor Heterodimers Exhibit Unique Functional Properties*

P. Sokoloff, Z. Vogel, R. Levenson, 2001, The Journal of Biological Chemistry.

Inhibition of AC-II activity following chronic agonist exposure is modulated by phosphorylation

Z. Vogel, E. Schallmach, Debora Steiner, 2007, Journal of Molecular Neuroscience.

Adenylyl cyclase type II activity is regulated by two different mechanisms: Implications for acute and chronic opioid exposure

Z. Vogel, E. Schallmach, Debora Steiner, 2006, Neuropharmacology.